(Q28079132)

Mark El-Deiry

2

1 reference

Jason R. Parks

3

1 reference

Kristin A. Higgins

4

1 reference

Nabil F. Saba

5

1 reference

language of work or name

1 reference

29 November 2016

1 reference

1 reference

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Why the epidermal growth factor receptor? The rationale for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Unequal burden of head and neck cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Cancer statistics for African Americans, 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Epidemiology of laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Tobacco use and cancer causation: association by tumour type

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Occupational exposures and cancer of the larynx-systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Red meat and cancer risk in a network of case-control studies focusing on cooking practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Diet diversity and the risk of laryngeal cancer: a case-control study from Italy and Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Gastroesophageal reflux and carcinoma of larynx or pharynx: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Laryngeal cancer: diagnosis and preoperative work-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Impact of Radiotherapy Dose on Dentition Breakdown in Head and Neck Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Functional Anatomy and Oncologic Barriers of the Larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Contemporary Surgical Management of Early Glottic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Endoscopic management of selected early vocal cord carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Health status and voice outcome after treatment for T1a glottic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Longitudinal Voice Outcomes Following Advanced CO2 Laser Cordectomy for Glottic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Factors predictive of survival in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Transoral laser microsurgery for advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512).

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Nutritional surveillance and weight loss in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Trade-off between survival and laryngeal preservation in advanced laryngeal cancer: the otorhinolaryngology patient's perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

The Challenges of Laryngeal Preservation-Is It the Systemic Agent or the Proper Sequence of Therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Outcomes of elective total laryngectomy for laryngopharyngeal dysfunction in disease-free head and neck cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Pectoralis major myofascial onlay and myocutaneous flaps and pharyngocutaneous fistula in salvage laryngectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Pectoralis myofascial flap during salvage laryngectomy prevents pharyngocutaneous fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Impact of pharyngeal closure technique on fistula after salvage laryngectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Pectoralis major myocutaneous flap versus free fasciocutaneous flap for reconstruction of partial hypopharyngeal defects: what should we be doing?

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Pharyngoesophageal reconstruction with the anterolateral thigh flap after total laryngopharyngectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Radial forearm free flap pharyngoesophageal reconstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Reconstruction of the hypopharynx with the free jejunum transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Laparoscopic harvest of the jejunal free flap for reconstruction of hypopharyngeal and cervical esophageal defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Comparison of voice outcomes after radial forearm free flap reconstruction versus primary closure after laryngectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Voice outcomes following reconstruction of laryngopharyngectomy defects using the radial forearm free flap and the anterolateral thigh free flap

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Communication after laryngectomy. An assessment of patient satisfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Voice Restoration After Total Laryngectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Platinum-based chemotherapy plus cetuximab in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Immunology and Immunotherapy of Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Comprehensive genomic characterization of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Postlaryngectomy Voice Rehabilitation: State of the Art at the Millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

ABCLOVE: Voice therapy outcomes for patients with head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

The role of pectoralis major myofascial flap in salvage laryngectomy: A single surgeon experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21386

21 January 2018

Identifiers

DOI

10.3322/CAAC.21386

0 references

PubMed publication ID

27898173

1 reference